None of you guys have been here long enough to know the REAL Iome. He used to be called "the godfather" here. Used to have Great insight and incredibly bullish. I believe he is from Italy.
Remember my odd call with IR? Inquisitive I will not call till after earnings because they will not comment about anything. That is exactly what she said. It was so strange. I called 1 month ago.
This stock has a wierd way about moving before news.
You think this is just a Technical move? I agree it is a technical move as this chart is sweet, but I think things are also falling in place fundamentally. I enjoy reading your posts. Can you explain a little more about why you think this is purely a tech move? I just think things are coming together nicely as shorts are covering ahead of fruition.
2 red thumbs for facts....hmm I am thinking there are some scared shorts here. Cover up boys n gals because it looks like this week is going to be fun.
Seems like smart money knows whats going on...GLTA, BTX is the future of reg med. It has its hand in everything! Renevia is safe and will be priven effective. Lookout guys n gals its going to treat an unmet med need
haha hey pal, d rose is healthy finally! Knicks hate playing the bulls! Bulls are their demise! I post less here but like stopping in for some of our long time posters like candi and the rest. I hold a BIG position here now. Wish me the best. What you holding now? GLTU old friend
There are people here with a personal vendetta against btx. Stem cells are real and have the potential to change how we treat diseases. I am long and not selling till this becomes a reality.
-Renevia is safe and its goal is to treat an unmet med need
-Asterias going to raise 15 mill
-BioTime announced changes to the organization and management of its research products business. The research products business will be consolidated into a new ESI BIO Division which shall be BioTime’s primary developer, manufacturer and distributor for its growing portfolio of stem-cell-based research products. Jeffrey Janus, BioTime’s vice president of sales and marketing, will lead ESI BIO and has also been appointed as the CEO of BioTime’s Singapore-based subsidiary ES Cell International which will be a part of the ESI BIO Division.
He also said this: "invest in a company that an idiot could run, because one will probably run it at some time."